You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 8, 2024

CLINICAL TRIALS PROFILE FOR ARIMOCLOMOL CITRATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for arimoclomol citrate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03491462 ↗	Arimoclomol in Amyotropic Lateral Sclerosis	Completed	Orphazyme	Phase 3	2018-07-31	A multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of arimoclomol in amyotropic lateral sclerosis (ALS)
NCT03836716 ↗	Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial	Terminated	Orphazyme	Phase 3	2019-09-19	A multicenter, non-randomized, open label trial, to assess long term safety and efficacy of Arimoclomol in subjects with Amyotrophic Lateral Sclerosis (ALS)who have completed the ORARIALS-01 trial.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for arimoclomol citrate

Condition Name

Chart
Table

Condition Name for arimoclomol citrate
Intervention	Trials
Amyotrophic Lateral Sclerosis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for arimoclomol citrate
Intervention	Trials
Sclerosis	2
Motor Neuron Disease	2
Amyotrophic Lateral Sclerosis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for arimoclomol citrate

Trials by Country

Map
Table

Trials by Country for arimoclomol citrate
Location	Trials
United States	16
Canada	3
Poland	2
France	2
Netherlands	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for arimoclomol citrate
Location	Trials
Virginia	2
Pennsylvania	2
Oregon	2
New York	2
Florida	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for arimoclomol citrate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for arimoclomol citrate
Clinical Trial Phase	Trials
Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for arimoclomol citrate
Clinical Trial Phase	Trials
Completed	1
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for arimoclomol citrate

Sponsor Name

Chart
Table

Sponsor Name for arimoclomol citrate
Sponsor	Trials
Orphazyme	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for arimoclomol citrate
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.